ORCHIDPHAR

Promoters of Orchid Pharma Limited has informed the Exchange regarding disclosure under regulation 30(2) and 31(4) of SEBI (SAST) Regulations, 2011

Dhanuka Laboratories Limited has informed the Exchange regarding its Report under Regulation 10(6) of Securities and Exchange Board of India (SAST)Regulations, 2011

K Raghavendra Rao has informed the Exchange regarding reason for encumbrance vide letter dated October 18, 2019 under SEBI ( SAST) Regulations, 2011.

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

SBICAP Trustee Company Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Rajagopal K has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao For and on behalf of Promoters & Promoter Group has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Rajagopal K has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

SBICAP Trustee Company Ltd. has submitted to the Exchange the disclosure under regulation 30(1) and 30(2) of SEBI (SAST) Regulations, 2011.

Promoters of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao, Rajagopal K, Bhuvana Mani & Kota Swarnalatha has submitted to the Exchange vide letter dated April 08, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Rajagopal K has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kota Swarnalatha has submitted to the Exchange vide letter dated April 13, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Bhuvana Mani has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

SBICAP Trustee Company Ltd has submitted to the Exchange vide its letter dated February 24, 2015 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Orchid Health Care Private Limited has submitted to the Exchange vide letter dated December 24, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Orchid Healthe care Private Ltd has submitted to the Exchange vide letter dated December 24, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Orchid Healthcare Private Ltd has submitted to the Exchange vide letter dated December 24, 2014 a Copy of Disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange, vide letter dated August 19, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao has submitted to the Exchange vide letter dated May 14, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

R. Vijayalakshmi has submitted to the Exchange vide letter dated April 04, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated March 15, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao has submitted to the Exchange vide letter dated January 23, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K Raghavendra Rao has submitted to the Exchange vide its letter dated January 04, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

R. Vijayalakshmi has submitted to the Exchange vide letter dated December 28, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated October 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated October 17, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated August 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Bhoomijha Murali has submitted to the Exchange vide letter dated August 23, 2012 a copy of disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

K. Raghavendra Rao has submitted to the Exchange vide letter dated July 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Adurjee & Bros. Private Limited has submitted to the Exchange vide letter dated July 23, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

K. Raghavendra Rao has submitted to the Exchange vide letter dated July 16, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 .

R. Vijayalakshmi has submitted to the Exchange vide its letter dated March 01, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 .

R. Vijayalakshmi has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange a copy of disclosure under Regulation 13(3) and (6) of the Securities and Exchange Board of India (Prohibhition of Insider Trading) Regulations, 1992.

R. Vijayalakshmi has submitted to the Exchange a copy of Disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and Disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

R. Vijayalakshmi has submitted to the Exchange a copy of Disclosure under regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Compensation Committee of the Board at its meeting held on November 01, 2011, has approved the following : (1) The issue of 42,700 stock options to the employees of the Company under Orchid ESOP - Senior Management 2011 Scheme. The said stock options are to be issued at par and are convertible into equity shares of Rs. 10/- each; (2) The issue of 3,00,000 stock options to the Directors of the Company under Orchid ESOP - Directors 2011 Scheme. These options are convertible into equity shares of Rs. 10/- each at a pric

Orchid Chemicals & Pharmaceuticals Limited the Exchange a copy of disclosure under Regulation 13(3) and (6) of the Securities and Exchange Board of India (Prohibhition of Insider Trading) Regulations, 1992.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Disclosure under Reg.8A(4) of SEBI (Substantial Acquisition of Share and Takeovers) Regulation, 1997.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure in terms of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure in terms of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure in terms of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange copies of disclosures in terms of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Orchid Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and takeovers) Regulations, 1997.

Orchid Chemicals & Pharmaceuticals Ltd has submitted to the Exchange the Forms as received by the company from M/s. Adurjee & Bros. Private Limited. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/orchid_adurjee_23112009.zip target=NEW> For more details click here.</a>

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that Mr. Raj RajKumar, Director has acquired 13,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.on June 13, 2006. The mode of acquisition is Market Purchase and the shareholding of Mr. Raj RajKumar after the said acquisition is 70,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that Mr. Raj RajKumar, Director has acquired 7,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.on June 08, 2006. The mode of acquisition is Market Purchase and the shareholding of Mr. Raj RajKumar after the said acquisition is 57,000 shares of Orchid Chemicals & Pharmaceuticals Ltd.